Ribonuclease inhibitor regulates neovascularization by human angiogenin

Biochemistry

Volumn 48, Issue 18, 2009, Pages 3804-3806

  Dickson, Kimberly A ^a,d   Kang, Dong Ku ^b   Young, Sam Kwon ^c   Jae, Chan Kim ^c   Leland, Peter A ^a   Kim, Byung Moon ^a   Chang, Soo Ik ^b   Raines, Ronald T ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Chungbuk National University   (South Korea)

^c Chung Ang University   (South Korea)

^d LAWRENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANGIOGENIC FACTOR; ANGIOGENIN; BIOLOGICAL ACTIVITIES; BLOOD VESSEL GROWTH; BOVINE PANCREATIC RIBONUCLEASE; CATALYTIC ACTIVITY; CYTOSOLIC; IN-VIVO; INHIBITOR PROTEINS; MAMMALIAN HOMOLOGUES; NEOVASCULARIZATION; RNASE A; WILD TYPES;

BLOOD VESSELS; MAMMALS;

ENZYMES;

ANGIOGENIN; RIBONUCLEASE A; RIBONUCLEASE INHIBITOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CORNEA; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REGULATORY MECHANISM;

ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEOVASCULARIZATION, PATHOLOGIC; RIBONUCLEASE, PANCREATIC; RIBONUCLEASES;

BOVINAE; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 66149119373     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi9005094     Document Type: Article

References (32)

1. Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., and Vallee, B. L. (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480-5486. (Pubitemid 16228828)
2. Olson, K. A., Byers, H. R., Key, M. E., and Fett, J. W. (2001) Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin. Cancer Res. 7, 3598-3605. (Pubitemid 33070000)
3. Olson, K. A., Byers, H. R., Key, M. E., and Fett, J. W. (2002) Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int. J. Cancer 98, 923-929.
4. Raines, R. T. (1998) Ribonuclease A. Chem. Rev. 98, 1045-1065.
5. Pizzo, E., and D'Alessio, G. (2007) The success of the RNase scaffold in the advance of biosciences and in evolution. Gene 406, 8-12. (Pubitemid 350216290)
6. Marshall, G. R., Feng, J. A., and Kuster, D. J. (2008) Back to the future: Ribonuclease A. Biopolymers 90, 259-277.
7. Bläaser, J., Triebel, S., Kopp, C., and Tschesche, H. (1993) A highly sensitive immunoenzymometric assay for the determination of angiogenin. Eur. J. Clin. Chem. Clin. Biochem. 31, 513-516. (Pubitemid 23262822)
8. Moenner, M., Gusse, M., Hatzi, E., and Badet, J. (1994) The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur. J. Biochem. 226, 483-490. (Pubitemid 24379067)
9. Hu, G. F., Riordan, J. F., and Vallee, B. L. (1997) A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 94, 2204-2209. (Pubitemid 27136852)
10. Moroianu, J., and Riordan, J. F. (1994) Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl. Acad. Sci. U.S.A. 91, 1677-1681. (Pubitemid 24080268)
11. Shapiro, R., Fox, E. A., and Riordan, J. F. (1989) Role of lysines in human angiogenin: Chemical modification and site-directed mutagenesis. Biochemistry 28, 1726-1732. (Pubitemid 19072045)
12. Xu, Z. P., Tsuji, T., Riordan, J. F., and Hu, G. F. (2002) The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem. Biophys. Res. Commun. 294, 287-292. (Pubitemid 34694091)
13. Jimi, S., Ito, K., Kohno, K., Ono, M., Kuwano, M., Itagaki, Y., and Ishikawa, H. (1995) Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem. Biophys. Res. Commun. 211, 476-483.
14. Hu, G., Riordan, J. F., and Vallee, B. L. (1994) Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc. Natl. Acad. Sci. U.S.A. 91, 12096-12100. (Pubitemid 24368611)
15. Dickson, K. A., Haigis, M. C., and Raines, R. T. (2005) Ribonuclease inhibitor: Structure and function. Prog. Nucleic Acid Res. Mol. Biol. 80, 349-374.
16. Papageorgiou, A., Shapiro, R., and Acharya, K. (1997) Molecular recognition of human angiogenin by placental ribonuclease inhibitor: An X-ray crystallographic study at 2.0 Å resolution. EMBO J. 16, 5162-5177. (Pubitemid 27380125)
17. Lee, F. S., Shapiro, R., and Vallee, B. L. (1989) Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry 28, 225-230. (Pubitemid 19046737)
18. Vicentini, A. M., Kieffer, B., Matthies, R., Meyhack, B., Hemmings, B. A., Stone, S. R., and Hofsteenge, J. (1990) Protein chemical and kinetic characterization of recombinant porcine ribonuclease inhibitor expressed in Saccharomyces cerevisiae. Biochemistry 29, 8827-8834. (Pubitemid 20302782)
19. Haigis, M. C., Kurten, E. L., and Raines, R. T. (2003) Ribonuclease inhibitor as an intracellular sentry. Nucleic Acids Res. 31, 1024-1032. (Pubitemid 36240441)
20. Rutkoski, T. J., and Raines, R. T. (2008) Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity. Curr. Pharm. Biotechnol. 9, 185-189.
21. Leland, P. A., Staniszewski, K. E., Park, C., Kelemen, B. R., and Raines, R. T. (2002) The ribonucleolytic activity of angiogenin. Biochemistry 41, 1343-1350. (Pubitemid 34083789)
22. Shapiro, R., and Vallee, B. L. (1987) Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl. Acad. Sci. U.S.A. 84, 2238-2241. (Pubitemid 17075846)
23. Polakowski, I. J., Lewis, M. K., Muthukkaruppan, V., Erdman, B., Kubai, L., and Auerbach, R. (1993) A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice. Am. J. Pathol. 143, 507-517. (Pubitemid 24058206)
24. Smith, B. D., and Raines, R. T. (2006) Genetic selection for critical residues in ribonucleases. J. Mol. Biol. 362, 459-478. (Pubitemid 44307153)
25. Riordan, J. F. (2001) Angiogenin. Methods Enzymol. 341, 263-273.
26. Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. (2003) Angiogenesis assays: A critical overview. Clin. Chem. 49, 32-40. (Pubitemid 36078551)
27. Lutter, G., Quaden, R., and Cremer, J. (2004) Biological bypass in cardiovascular surgery. Thorac. Cardiovasc. Surg. 52, 237-248. (Pubitemid 39099891)
28. Tello-Montoliu, A., Patel, J. V., and Lip, G. Y. H. (2006) Angiogenin: A review of the pathophysiology and potential clinical applications. J. Thromb. Haemostasis 4, 1864-1874.
29. Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., Morrison, K. E., Green, A., Acharya, K. R., Brown, R. H. Jr., and Hardiman, O. (2006) ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 38, 411-413.
30. Crabtree, B., Thiyagarajan, N., Prior, S. H., Wilson, P., Iyer, S., Ferns, T., Shapiro, R., Brew, K., Subramanian, V., and Acharya, K. R. (2007) Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 46, 11810-11818. (Pubitemid 47623749)
31. Kishikawa, H., Wu, D., and Hu, G.-f. (2008) Targeting angiogenin in therapy of amyotrophic lateral sclerosis. Expert Opin. Ther. Targets 12, 1229-1242.
32. Wells, J. A., and McClendon, C. L. (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001-1009. (Pubitemid 350273630)